跳至主要内容
临床试验/CTRI/2020/09/028122
CTRI/2020/09/028122已完成3 期

Homoeopathic medicines in the prevention of COVID-19 among high risk individuals: A community based, double-blind randomized controlled trial

Ministry of AYUSH Govt of India0 个研究点目标入组 4,034 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
4,034

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Persons residing in the ward no. 27 under Howrah Municipal Corporation.
  • d)Person giving consent to participate (guardian’s consent in cases of minors)

排除标准

  • a)Diagnosed cases of COVID-19 or persons with related symptoms
  • b)People who have already taken homoeopathic medicines in some forms within the last 15 days
  • c)Cases with vital organ failure
  • d)Immune compromised state

研究者

发起方
Ministry of AYUSH Govt of India

相似试验